WHO names Resomelagon among key dengue drug candidates
SynAct Pharma AB OMXSTO:SYNACT is mentioned in a TradingView News item stating the WHO named Resomelagon among key dengue drug candidates.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.